{"id":49398,"date":"2022-10-07T19:02:02","date_gmt":"2022-10-07T17:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/outlook-on-the-assisted-reproductive-technology-global-market-to-2030-featuring-cosmos-biomedical-coopersurgical-and-ferring-among-others-researchandmarkets-com\/"},"modified":"2022-10-07T19:02:02","modified_gmt":"2022-10-07T17:02:02","slug":"outlook-on-the-assisted-reproductive-technology-global-market-to-2030-featuring-cosmos-biomedical-coopersurgical-and-ferring-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/outlook-on-the-assisted-reproductive-technology-global-market-to-2030-featuring-cosmos-biomedical-coopersurgical-and-ferring-among-others-researchandmarkets-com\/","title":{"rendered":"Outlook on the Assisted Reproductive Technology Global Market to 2030 – Featuring Cosmos Biomedical, CooperSurgical and Ferring Among Others – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Assisted Reproductive Technology Market Size, Share & Trends Analysis Report by Type (IVF, Artificial Insemination), by End-use (Fertility Clinics & Other Facilities, Hospitals & Other Settings), by Region, and Segment Forecasts, 2022-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global assisted reproductive technology market size is expected to reach USD 41.4 billion by 2030, according to this report. It is expected to register a CAGR of 6.15% during the forecast period.\n<\/p>\n

\nThe growth of the market is mainly driven by the rising cases of infertility globally. In addition, the growing awareness about infertility and treatment methods available to conceive a child is expected to boost the industry growth during the forecast period. The rising adoption of Assisted Reproductive Technologies (ART) by couples and prospective parents trying for children is expected to boost the industry’s growth.\n<\/p>\n

\nFurthermore, the increasing use of technologies in ART, such as Artificial Intelligence (AI) and Machine learning (ML), for research and development is expected to improve patient outcomes.\n<\/p>\n

\nFor instance, as per the article published in the National Library of Medicine, Preimplantation genetic testing for aneuploidies (PGT-A), when coupled with IVF, showed positive results in reversal of the effect of maternal age on the rates of implantation and also a decrease in miscarriage rates were shown in the study, especially for frozen transfers.\n<\/p>\n

\nThe COVID-19 pandemic adversely affected the industry owing to the cancellation and postponed procedures and a reduction of patient visits to fertility clinics. It adversely affected the mental health of the couples undergoing ART due to the cancellation of the procedures for IVF and artificial insemination.\n<\/p>\n

\nThe market is now slowly regaining to the pre-pandemic rates due to relaxation in the restrictions. Key companies operating in the market are adopting various strategies to gain higher market share, such as mergers and acquisitions. For instance, in January 2019, Ferrings Pharmaceuticals acquired the U.S. commercialization rights for the Ganirelix Acetate injection generic from Sun Pharma and expands its reproductive medicine portfolio to provide resources and services for ART.\n<\/p>\n

\nAssisted Reproductive Technology Market Report Highlights<\/strong>\n<\/p>\n